An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses

NCT04549792 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Ichthyosis

Interventions

DRUG: Ustekinumab

Sponsor

Northwestern University

Collaborators

[object Object]